drugset / Trial / NCT03403452
Apatinib in the Treatment of Metastatic Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is an Exploratory Clinical Trial Study on Apatinib in the Treatment of Metastatic Colorectal Cancer Who Have Progressed after Standard Second Line Therapy.
Timeline
- Start
- 2018-01-01
- Primary completion
- 2019-06-30
- Completion
- 2019-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | 500 mg | Oral |